More from Dividend.com
Referenced Stocks

Pfizer Started as a “Buy” at ISI Group (PFE)

By Dividend.com,  April 10, 2012, 09:07:57 AM EDT

Pharmaceuticals giant Pfizer Inc. ( PFE ) on Tuesday caught some bullish commentary from analysts at ISI Group.

The firm said it initiated coverage on PFE with a "Buy" rating and $25 price target, suggesting a 13% upside to the stock's Monday closing price of $22.05.

Pfizer shares, which have risen about 2% year-to-date, posted modest gains in premarket trading Tuesday.

The Bottom Line
We have been recommending shares of Pfizer ( PFE ) since Mar.2, when the stock was trading at $21.49. The company has a 3.99% dividend yield, based on last night's closing stock price of $22.05.

Pfizer Inc. ( PFE ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.


This article appears in: Investing, Stocks

Referenced Stocks: PFE



Latest News Video

Susan Powell Search Ends
Susan Powell Search Ends            
Violence Rages in Syria Amid Hopes For Peace Talks
Violence Rages in Syria Amid Hopes ...


Sign-in
Existing NASDAQ.com member? Log in here.

By signing into to the site using any of the third-party services above, you agree to NASDAQ.com's Terms of Use.

From Our Trusted News Source





Most Active by Volume:

Company Last Sale Change Net / %
BAC $ 13.4731 0.04  0.27%
F $ 15.005 0.05  0.30%
SIRI $ 3.50 unch
CLWR $ 3.42 0.16  4.91%
MSFT $ 35.0176 0.06  0.18%
YGE $ 3.66 0.56  18.06%
PFE $ 28.77 0.07  0.24%
CSCO $ 23.95 0.01  0.02%